KP.2 is one of several variants referred to as “FLiRT variants,” named after the specific mutations they possess.
KP.2 is one of several variants referred to as “FLiRT variants,” named after the specific mutations they possess.
After almost four years of COVID-19, collecting data isn’t as detailed as before. So, what do we really know about how big this wave is?
Post-pandemic, it may seem like you and your family are getting sick more frequently, and when you do catch a cold, it lingers longer.
Could nasal vaccines provide better protection than mRNA vaccines? Here’s what preclinical trial’s have to say.
Starting December 11, Australians will gain access to new monovalent booster vaccines.
Brown University found that older adults have a smaller chance of having bad reactions after getting the Moderna vaccine compared to the Pfizerr vaccine
What if you could test for COVID-19 by breathing into a portable device and know your result in a minute?
Moderna has recently made headlines by emphasising its focus on the development of a ‘super jab’ to tackle COVID-19, flu, and RSV.
Moderna has applied for an updated COVID-19 vaccine authorisation with the US Food and Drug Administration (FDA).
Just over 40% of aged care residents estimated eligible for a booster vaccination have had their latest shot and are fully vaccinated.